141 related articles for article (PubMed ID: 11595891)
1. The systematic relationship between melanomas diagnosed in situ and when invasive.
Lee JA
Melanoma Res; 2001 Oct; 11(5):523-9. PubMed ID: 11595891
[TBL] [Abstract][Full Text] [Related]
2. Distribution of subsequent primary invasive melanomas following a first primary invasive or in situ melanoma Queensland, Australia, 1982-2010.
Youlden DR; Youl PH; Soyer HP; Aitken JF; Baade PD
JAMA Dermatol; 2014 May; 150(5):526-34. PubMed ID: 25093216
[TBL] [Abstract][Full Text] [Related]
3. Trends in the diagnosis and clinical features of melanoma in situ (MIS) in US men and women: A prospective, observational study.
Wei EX; Qureshi AA; Han J; Li TY; Cho E; Lin JY; Li WQ
J Am Acad Dermatol; 2016 Oct; 75(4):698-705. PubMed ID: 27436155
[TBL] [Abstract][Full Text] [Related]
4. Trends for in situ and invasive melanoma in Queensland, Australia, 1982-2002.
Coory M; Baade P; Aitken J; Smithers M; McLeod GR; Ring I
Cancer Causes Control; 2006 Feb; 17(1):21-7. PubMed ID: 16411049
[TBL] [Abstract][Full Text] [Related]
5. National utilization patterns of Mohs micrographic surgery for invasive melanoma and melanoma in situ.
Viola KV; Rezzadeh KS; Gonsalves L; Patel P; Gross CP; Yoo J; Stamell E; Turner RB
J Am Acad Dermatol; 2015 Jun; 72(6):1060-5. PubMed ID: 25824274
[TBL] [Abstract][Full Text] [Related]
6. Incidence of In Situ and Invasive Melanoma in Denmark From 1985 Through 2012: A National Database Study of 24,059 Melanoma Cases.
Helvind NM; Hölmich LR; Smith S; Glud M; Andersen KK; Dalton SO; Drzewiecki KT
JAMA Dermatol; 2015 Oct; 151(10):1087-95. PubMed ID: 26061591
[TBL] [Abstract][Full Text] [Related]
7. Increasing time trends of thin melanomas in The Netherlands: What are the explanations of recent accelerations?
van der Leest RJ; Zoutendijk J; Nijsten T; Mooi WJ; van der Rhee JI; de Vries E; Hollestein LM
Eur J Cancer; 2015 Dec; 51(18):2833-41. PubMed ID: 26589973
[TBL] [Abstract][Full Text] [Related]
8. The acceleration of melanoma in situ: A population-based study of melanoma incidence trends from Victoria, Australia, 1985-2015.
Curchin DJ; Forward E; Dickison P; Harris VR; McCormack CJ; Smith SD
J Am Acad Dermatol; 2019 Jun; 80(6):1791-1793. PubMed ID: 31103160
[No Abstract] [Full Text] [Related]
9. Assessment of Cutaneous Squamous Cell Carcinoma (cSCC) In situ Incidence and the Risk of Developing Invasive cSCC in Patients With Prior cSCC In situ vs the General Population in the Netherlands, 1989-2017.
Tokez S; Wakkee M; Louwman M; Noels E; Nijsten T; Hollestein L
JAMA Dermatol; 2020 Sep; 156(9):973-981. PubMed ID: 32609322
[TBL] [Abstract][Full Text] [Related]
10. Body site distribution of cutaneous malignant melanoma in relationship to patterns of sun exposure.
Elwood JM; Gallagher RP
Int J Cancer; 1998 Oct; 78(3):276-80. PubMed ID: 9766557
[TBL] [Abstract][Full Text] [Related]
11. The burden of malignant melanoma--lessons to be learned from Austria.
Monshi B; Vujic M; Kivaranovic D; Sesti A; Oberaigner W; Vujic I; Ortiz-Urda S; Posch C; Feichtinger H; Hackl M; Rappersberger K
Eur J Cancer; 2016 Mar; 56():45-53. PubMed ID: 26802530
[TBL] [Abstract][Full Text] [Related]
12. In situ and invasive melanoma in a high-risk, New Zealand, population: A population-based study.
Elwood JM; Kim SJ; Ip KH; Oakley A; Rademaker M
Australas J Dermatol; 2019 Feb; 60(1):38-44. PubMed ID: 30051460
[TBL] [Abstract][Full Text] [Related]
13. Risk of subsequent melanoma after melanoma in situ and invasive melanoma: a population-based study from 1973 to 2011.
Pomerantz H; Huang D; Weinstock MA
J Am Acad Dermatol; 2015 May; 72(5):794-800. PubMed ID: 25769192
[TBL] [Abstract][Full Text] [Related]
14. Incidence of in Situ vs Invasive Melanoma: Testing the "Obligate Precursor" Hypothesis.
Olsen CM; Pandeya N; Rosenberg PS; Whiteman DC
J Natl Cancer Inst; 2022 Oct; 114(10):1364-1370. PubMed ID: 36042554
[TBL] [Abstract][Full Text] [Related]
15. Melanoma in situ: Part I. Epidemiology, screening, and clinical features.
Higgins HW; Lee KC; Galan A; Leffell DJ
J Am Acad Dermatol; 2015 Aug; 73(2):181-90, quiz 191-2. PubMed ID: 26183967
[TBL] [Abstract][Full Text] [Related]
16. Skin cancer. Melanoma and other specific nonmelanoma skin cancers.
Elder DE
Cancer; 1995 Jan; 75(1 Suppl):245-56. PubMed ID: 8000999
[TBL] [Abstract][Full Text] [Related]
17. Melanoma survival is superior in females across all tumour stages but is influenced by age.
Khosrotehrani K; Dasgupta P; Byrom L; Youlden DR; Baade PD; Green AC
Arch Dermatol Res; 2015 Oct; 307(8):731-40. PubMed ID: 26103951
[TBL] [Abstract][Full Text] [Related]
18. Changing age distribution of melanoma patients: a 22-year, single-site perspective.
Paul J; Sbicca JA; Hirano SA; Mushti S; Pariser RJ
South Med J; 2013 Dec; 106(12):667-72. PubMed ID: 24305524
[TBL] [Abstract][Full Text] [Related]
19. Site, histological type, and thickness of primary cutaneous malignant melanoma in western Netherlands since 1980.
van der Spek-Keijser LM; van der Rhee HJ; Tóth G; Van Westering R; Bruijn JA; Coebergh JW
Br J Dermatol; 1997 Apr; 136(4):565-71. PubMed ID: 9155959
[TBL] [Abstract][Full Text] [Related]
20. The significance of crystalline/chrysalis structures in the diagnosis of melanocytic and nonmelanocytic lesions.
Balagula Y; Braun RP; Rabinovitz HS; Dusza SW; Scope A; Liebman TN; Mordente I; Siamas K; Marghoob AA
J Am Acad Dermatol; 2012 Aug; 67(2):194.e1-8. PubMed ID: 22030020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
